Perceptions, policies, and practices related to dispensing buprenorphine for opioid use disorder: A national survey of community-based pharmacists

Study protocol for the Respond to Prevent Study: a multi-state randomized controlled trial to improve provision of naloxone, buprenorphine and nonprescription syringes in community pharmacies

(2022) Traci C. Green et al.   Substance Abuse

Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in 11 U.S. states

(2022) Lucas G. Hill et al.   DRUG AND ALCOHOL DEPENDENCE

‘Red Flags’ and ‘Red Tape’: Telehealth and pharmacy-level barriers to buprenorphine in the United States

(2022) Lauren Textor et al.   INTERNATIONAL JOURNAL OF DRUG POLICY

Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018

(2021) Byungkyu Lee et al.   JAMA Network Open

Pharmacists’ stigma toward patients engaged in opioid misuse: When “social distance” does not mean disease prevention

(2021) Amy Werremeyer et al.   Substance Abuse

Pharmacy-related buprenorphine access barriers: An audit of pharmacies in counties with a high opioid overdose burden

(2021) Neda J. Kazerouni et al.   DRUG AND ALCOHOL DEPENDENCE

Ensuring buprenorphine access in rural community pharmacies to prevent overdoses

(2021) Bayla Ostrach et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Implementation of academic detailing for pharmacists on opioid use disorder and harm reduction

(2021) Bethany A. DiPaula et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Socio-ecological and pharmacy-level factors associated with buprenorphine stocking at pharmacies in New York City

(2021) Phillip L. Marotta et al.   INTERNATIONAL JOURNAL OF DRUG POLICY

Indiana community pharmacist preceptors’ knowledge and perceptions of medication-assisted treatment

(2020) Elizabeth S. Davenport et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

When Prescribing Isn’t Enough — Pharmacy-Level Barriers to Buprenorphine Access

(2020) Hannah L.F. Cooper et al.   NEW ENGLAND JOURNAL OF MEDICINE

Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Texas, USA

(2020) Lucas G. Hill et al.   ADDICTION

Impact of student pharmacist–led naloxone academic detailing at community pharmacies in Texas

(2019) Kirk E. Evoy et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Communication Experiences of DATA-Waivered Physicians with Community Pharmacists: A Qualitative Study

(2019) Daniel J. Ventricelli et al.   SUBSTANCE USE & MISUSE

Understanding the use of diverted buprenorphine

(2018) Theodore J. Cicero et al.   DRUG AND ALCOHOL DEPENDENCE

Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia

(2017) J. Douglas Thornton et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION